Welcome to jctrans.net , Join Free |  Sign In
GMT+8 TUESDAY  13:40 2013/01/29 中文站
Exhibitions

Executive Talks

1of5

Interview with Milad M Istefanous, Executive Director of Philomina Global Services Co. Ltd.

Interview with Milad M Istefanous, Executive Director of Philomina Global Services Co. Ltd.

Philomina Global Head office located at Khartoum City that is well known, and having branches @ Port Sudan (Seaport City), and our modern office systems and all staff to give excellent services to our potential customers and worldwide associates.

Interview with Filipe Garcia, Branch Manager of Inicio transitarios Lda

Interview with Filipe Garcia, Branch Manager of Inicio transitarios Lda

Since the year 2000 INÍCIO TRANSITÁRIOS has been dedicated with total commitment to the creation of door-to-door transport solutions, regarding maritime and air logistics, on an international basis.

Interview with Ken Zhu,of Coeffort (Shanghai) Logistics & SCM Co., Ltd

Interview with Ken Zhu,of Coeffort (Shanghai) Logistics & SCM Co., Ltd

Coeffort was established in January 2015, core business of Coeffort is supply chain management and provide professional solutions, including supply chain financing, supply chain design, procurement and distribution, international customs clearance agent, executive stock trusteeship, Department of outsourcing, outsourcing processing and distribution management, supply chain services. I hope our business can do for customers "time Save", "money Save", "way touching One".

Interview with Arturo Chavez, Commercial Manager  of Smart Logistics Group

Interview with Arturo Chavez, Commercial Manager of Smart Logistics Group

SMART LOGISTICS GROUP is a premier transportation and logistics company, with coverage in SPAIN/EUROPE. Our value-added services portfolio includes import and export freight management, truck brokerage, intermodal, load/mode and network optimization, and global visibility. We provide freight forwarding, customs brokerage, warehousing and all other logistics services.

Interview with Ordan Cargo, Managing Director of Ordan Cargo Ltd

Interview with Ordan Cargo, Managing Director of Ordan Cargo Ltd

We are " ORDAN CARGO LTD" a freight forwarding & logistics company based in Tel Aviv, Israel since 2001 having presences at all main ports ASHDOD/HAIFA/TLV for Import/Export/Cross SEA/AIR. We provide excellent and creative logistics solutions as well as quality service with competitive prices.

US Stock Futures Flat Ahead Of International Trade Data

Source:benzinga    2014-5-7 9:55:00

Pre-open movers

US stock futures traded mostly flat in early pre-market trade, ahead of international trade data. Data on international trade for March will be released at 8:30 a.m. ET. Futures for the Dow Jones Industrial Average dropped 5 points to 16,439.00, while the Standard & Poor's 500 index futures fell 0.40 points to 1,875.40. Futures for the Nasdaq 100 index gained 0.25 points to 3,591.00.

A Peek Into Global Markets

European markets were mixed today, with the Spanish Ibex Index rising 0.36%, STOXX Europe 600 Index gaining 0.08%. German DAX 30 index rose 0.04%, French CAC 40 Index declined 0.09% and London's FTSE 100 Index dropped 0.12%. UK's services PMI surged to 58.7 in April, from 57.6 in March.

In Asian markets, China's Shanghai Composite Index gained 0.03% and India's BSE Sensex rose 0.28%.

Broker Recommendation

Analysts at Bank of America upgraded Seattle Genetics (NASDAQ: SGEN [FREE Stock Trend Analysis]) from "underperform" to "neutral." The target price for Seattle Genetics has been lowered from $46 to $40.

Seattle Genetics' shares closed at $35.10 yesterday.

Breaking news

  • Xerox (NYSE: XRX) today announced a definitive agreement to acquire ISG Holdings, Inc. for $225 million, creating a comprehensive workers' compensation suite of offerings for clients in the property and casualty insurance industry. To read the full news, click here.
  • Astellas Pharma (OTC: ALPMY) and Medivation (NASDAQ: MDVN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the supplemental New Drug Application (sNDA) to extend the indication for XTANDI® (enzalutamide) capsules for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC) who have not received chemotherapy. To read the full news, click here.
  • Switzerland's bank UBS AG (NYSE: UBS) reported a 7% rise in its first-quarter profit. UBS posted its quarterly net profit of 1.054 billion Swiss francs ($1.2 billion), versus a year-ago profit of 988 million francs. To read the full news, click here.
  • Merck (NYSE: MRK) today announced that it has entered into a definitive agreement to sell its Merck Consumer Care (MCC) business to Bayer AG (OTC: BAYRY) for $14.2 billion. To read the full news, click here.